首页> 外国专利> Composition for Prevention or Treatment of Mental Disorders Comprising Extracellular Vesicles Derived from Lactobacillus

Composition for Prevention or Treatment of Mental Disorders Comprising Extracellular Vesicles Derived from Lactobacillus

机译:预防或治疗包含源自乳杆菌的细胞外囊泡的精神障碍的组合物

摘要

The present invention relates to a composition for prevention, improvement, or treatment of mental diseases including a bacterium-derived vesicle of the genus Lactobacillus as an effective ingredient. Since the inventors of the present invention have found that when an animal model of stress and depression is administered to a bacterium-derived vesicle of the genus Lactobacillus, the resistance to stress is effectively increased and a long-term chronic depressive action is effectively treated, it is expected that the present invention may be used for the development of medicines, health functional food, or the like so as to prevent, improve, and treat syndromes of the mental diseases such as stress, anxiety disorders, post-traumatic stress disorder, panic disorder, depression, autism spectrum disorders, attention deficit hyperactivity syndrome, schizophrenia, and the like.
机译:本发明涉及一种用于预防,改善或治疗精神疾病的组合物,该组合物包括乳酸菌属的细菌来源的囊泡作为有效成分。由于本发明的发明人已经发现,当将应激和抑郁的动物模型施用于乳酸杆菌属的细菌来源的囊泡时,可以有效提高对应激的抵抗力,并且可以有效地治疗长期的慢性抑郁作用,期望本发明可以用于药物,保健食品或类似物的开发,以预防,改善和治疗精神疾病的综合症,例如压力,焦虑症,创伤后应激障碍,恐慌症,抑郁症,自闭症谱系障碍,注意缺陷多动症,精神分裂症等。

著录项

  • 公开/公告号KR20180019482A

    专利类型

  • 公开/公告日2018-02-26

    原文格式PDF

  • 申请/专利权人 MD HEALTHCARE INC.;

    申请/专利号KR1020170100459

  • 发明设计人 KIM YOON KEUN;HAN PYUNG LIM;CHOI JU LI;

    申请日2017-08-08

  • 分类号A61K35/747;A23L33/135;A61K9;

  • 国家 KR

  • 入库时间 2022-08-21 12:40:47

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号